YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect.
- Resource Type
- Article
- Source
- Cell Death & Disease; Nov2018, Vol. 9 Issue 11, p1-10, 10p
- Subject
- Language
- ISSN
- 20414889